New imaging procedures in thyroid-associated ophthalmopathy

Orbit

Volumn 15, Issue 3, 1996, Pages 165-175

  Kahaly, George J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Magnetic resonance imaging; Octreotide scan; Thyroid associated ophthalmopathy

Indexed keywords

PENTETREOTIDE IN 111;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0029786462     PISSN: 01676830     EISSN: None     Source Type: Journal    
DOI: 10.3109/01676839609150234     Document Type: Article

References (33)

1. Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D. Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12:150-153.
2. Wall JR. Pathogenesis and management of thyroid associated ophthalmopathy: an update. Thyroid Today 1991; 14:1-9.
3. van der Gaag R, Schmidt ED, Koornneef L. Retrobulbar histology and immunohistochemistry in endocrine ophthalmopathy In: Kahaly G (editor). Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Basel: Karger, 1993; 1-10.
4. Kahaly G, Hansen C, Felke B, Dienes HP. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol 1994; 73:53-62.
5. Kroll AJ, Kuwabara T. Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy. Arch Ophthalmol 1966; 76:244-257.
6. Trokel SL, Jakobiec FA. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology 1981; 88:553-564.
7. Just M, Thelen M. Tissue characterisation using NMR tissue parameters: results in 160 patients with brain tumors. Radiology 1988; 169:779-785.
8. Hosten N, Sander B, Cordes M, Schubert CJ, Schörner W, Felix R. Graves' ophthalmopathy: MR imaging of the orbits. Radiology 1989; 172:759-762.
9. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 1989; 264:949-953.
10. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localisation of endocrine tumors. N Engl J Med 1990; 323:1246-1249.
11. Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe1)-octreotide in man: metabolism, dosimetry and comparison with (123-I-Tyr-3)-octreotide. J Nucl Med 1992; 33:652-658.
12. Classification of eye changes of Graves' disease. Thyroid 1992; 2:235-236.
13. Kahaly G, Diaz M, Hahn K, Beyer J, Bockisch A. Indium-111-Pentetreotide scintigraphy in Graves' ophthalmopathy. J Nucl Med 1995; 36:550-554.
14. Kahaly G, Diaz M, Just M, Beyer J, Lieb W. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy. Thyroid 1995; 5:107-111.
15. Wiersinga WM. Immunosuppression in endocrine ophthalmopathy. In: Kahaly G (editor). Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Basel: Karger, 1993; 120-130.
16. Krenning EP, Oei HY, Kooij PPM, et al. Thyroid and orbital radiolabelled Somatostatin accumulation in Graves' disease and Graves' ophthalmopathy. J Nucl Med 1992; 33:894 (Abstract).
17. Postema PTE, Krenning EP, Wijngaarde R, et al. [111In-DTPA-D-Phe1] Octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity. J Clin Endocrinol Metabol 1994; 79:1845-1851.
18. Krenning EP, Postema PTE, Wijngaarde R, et al. [In-111-DTPA-D-Phe-1] Octreotide scintigraphy in thyroidal and orbital Graves' disease: follow-up during treatment. Thyroid 1995; 5, suppl 1:S-183 (Abstract).
19. Moncayo R, Baldissera I, Metzler R, Decristoforo C, Riccabona G. Octreoscan in the evaluation of active Graves' ophthalmopathy. Thyroid 1995; 5. supp. 1:S-69 (Abstract).
20. Kahaly G, Stover C, Otto E, Beyer J, Schuler M. Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity 1992; 13:81-88.
21. Kahaly G, Stover C, Beyer J, Otto E. In vitro synthesis of glycosaminoglycans in endocrine ophthalmopathy. Acta Endocrinol 1992; 127:397-402.
22. Schuler M, Hansen C, Winand R, Stover C, Otto E, Beyer J, Kahaly G. Urinary and plasma glycosaminoglycans in endocrine ophthalmopathy. In: Kahaly G (editor). Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Basel: Karger, 1993; 58-67.
23. Kahaly G, Hansen C, Stover C, Beyer J, Otto E. Glycosaminoglycan antibodies in endocrine ophthalmopathy. Horm Met Res 1993; 25:637-639.
24. Kahaly G, Hansen C, Beyer J, Winand R. Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994; 17:45-50.
25. Kahaly G, Hansen C, Stover C, Kuhleman K, Beyer J, Otto E. Glycosaminoglycans and endocrine orbitopathy. Exp Clin Endocrinol 1994; 102:151-161.
26. Stover C, Otto E, Beyer J, Kahaly G. Cellular immunity and retrobulbar fibroblasts in Graves' ophthalmopathy. Thyroid 1994; 4:161-165.
27. Just M, Kahaly G, Higer HP, et al. Graves' ophthalmopathy: role of MR imaging in radiation therapy. Radiology 1991; 179:187-190.
28. Kahaly G, Just M, Lieb M, Stover C, Beyer J, Rösler HP. Magnetic resonance imaging in therapy of endocrine ophthalmopathy. Acta Endocrinol 1992; 126, suppl 4 151.
29. Hiromatsu Y, Kojima K, Ishisaka N, et al. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 1992; 2:299-305.
30. Ohnishi T, Noguchi S, Murakami N, et al. Extraocular muscles in Graves' ophthalmopathy: usefulness of T2 relaxation time measurements. Radiology 1994; 190:857-862.
31. Utech C, Khatibnia U, Winter P, Wulle K. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid 1995; 5:185-193.
32. Prummel MF, Suttorp-Schulten MSA, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology 1993; 100:556-561.
33. Kahaly G, Müller-Forell W, Beyer J. CT measurements of retrobulbar fat volume in endocrine orbitopathy. Acta Endocrinol 1991; 124:94.